Air quality and public health co-benefits of national transport policies
Clinical Snapshot
PICO Framework
| P — Population | General populations exposed to urban and regional air pollution from transport sources, across national and regional settings (primarily high-income countries, with limited representation from low- and middle-income countries) |
| I — Intervention | National or regional transport policies including diesel vehicle phase-outs, inspection and maintenance programmes, electric vehicle (EV) incentives, fuel taxation, fuel quality improvements, and promotion of public or active transport |
| C — Comparator | Baseline or counterfactual scenarios without the transport policy intervention (business-as-usual or pre-policy conditions) |
| O — Outcomes | Air quality outcomes (PM2.5 concentration reductions); public health outcomes (avoided premature mortality, respiratory and cardiovascular hospitalisations, healthcare cost savings) |
Bottom Line
This systematic review synthesises evidence from 10 studies on the air quality and public health co-benefits of national transport policies, finding consistent directional support for PM2.5 reductions and avoided premature mortality, respiratory and cardiovascular hospitalisations, and healthcare costs — particularly from integrated policy packages combining vehicle electrification, fuel quality regulation, diesel phase-out, and active transport promotion. However, the evidence base is critically small, no quantitative synthesis was possible, and formal certainty of evidence (GRADE) assessment is absent. The predominance of high-income country evidence limits global applicability. For Australian clinicians and public health practitioners, the findings directionally support advocacy for the recently legislated New Vehicle Efficiency Standard and broader EV transition policies, but the review cannot provide precise quantitative estimates of expected health gains in the Australian context. This review is best understood as a scoping synthesis that maps the landscape of evidence and identifies critical research gaps — particularly the urgent need for long-term health impact evaluations in low- and middle-income countries — rather than a definitive evidence base for specific policy decisions. Clinicians should treat its conclusions as hypothesis-generating and directionally informative rather than practice-changing.
Key Findings
P Value: Not reported
Effect Size: Not quantified; narrative synthesis only. Direction of effect consistently favourable across all 10 included studies for PM2.5 reduction and health co-benefits
Primary Outcome: Reductions in PM2.5 concentrations and avoided premature mortality associated with national/regional transport policies, with the largest and most consistent benefits observed for integrated policy packages combining regulatory, technological, and fiscal/behavioural instruments
Nnt Or Sensitivity: Not calculable from available data; no pooled estimates provided. Individual study estimates of avoided premature deaths and hospitalisation reductions are referenced narratively but not synthesised quantitatively
Confidence Interval: Not reported; no meta-analysis performed
Clinical Application
Transport policy interventions (EV incentives, fuel quality regulation, diesel phase-out, public transport investment) are feasible at national and subnational government levels. Clinical applicability is indirect — clinicians can advocate for these policies and counsel patients on the health benefits of reduced transport emissions, but implementation requires government and regulatory action. Health impact assessment integration into transport planning is feasible and recommended. Australia has direct policy relevance to this review. Australia currently lacks a national fuel efficiency standard equivalent to those in the EU or USA, though the New Vehicle Efficiency Standard (NVES) was legislated in 2024, representing a significant policy development aligned with the review's recommendations. The TGA and RACGP have both recognised air pollution as a modifiable determinant of cardiovascular and respiratory disease. The PBS does not directly intersect with transport policy, but reduced hospitalisations from improved air quality would reduce healthcare system burden. Australia's high rates of diesel vehicle ownership, urban traffic congestion in major cities (Sydney, Melbourne, Brisbane), and ongoing EV transition debates make this evidence directly pertinent to Australian public health policy. The review's finding that integrated packages (combining vehicle electrification, fuel quality regulation, and active transport promotion) yield the greatest co-benefits is consistent with recommendations from the Australian Institute of Health and Welfare and state-level clean air strategies. The underrepresentation of Asia-Pacific settings in the evidence base is a limitation for direct Australian application. Urban and peri-urban populations exposed to transport-related air pollution, particularly those with pre-existing cardiovascular and respiratory conditions who bear disproportionate burden from PM2.5 exposure. Populations in high-income countries with established vehicle fleets and regulatory capacity are most directly represented by the evidence base.
Abstract
INTRODUCTION: Transport is a major contributor to urban air pollution and premature mortality worldwide. This systematic review evaluates the air-quality and public health co-benefits of national and regional transport policies aimed at reducing population exposure to air pollution. CONTENT: Following PRISMA 2020 guidelines, this review synthesized evidence published between 2011 and 2024 on the health and environmental impacts of national or regional transport policies. Ten eligible studies were reviewed, covering diesel vehicle phase-outs, inspection and maintenance programs, electric vehicle incentives, fuel taxation, and promotion of public or active transport. SUMMARY: Across multiple settings, these policies were associated with reductions in PM2.5 concentrations and with avoided premature mortality, respiratory and cardiovascular hospitalizations, and healthcare costs. The largest and most consistent health benefits were observed for integrated policy packages, particularly those combining regulatory and technological measures such as fuel quality improvements, vehicle electrification and diesel phase-out, complemented by behavioral or fiscal instruments. Most available evidence originates from high-income countries, while studies from low- and middle-income regions remain scarce. The limited number of eligible studies and their concentration in specific regions and modeling approaches constrain generalizability, especially to settings with different transport systems, resource availability, and air-quality profiles. OUTLOOK: Embedding health-impact assessment within transport planning and expanding long-term evaluations in low- and middle-income countries are essential to ensure equitable and sustained air-quality and health improvements. Future policy frameworks should prioritize source-oriented regulatory and technological measures such as vehicle electrification, fuel-quality regulation, and diesel phase-out implemented within integrated policy packages to maximize public-health co-benefits.
References
- 1.Naw, A. T. H., Papong, S., Rattanapan, C., & Biró, K. (2026). Air quality and public health co-benefits of national transport policies. Reviews on Environmental Health. https://doi.org/10.3390/app10175970
Related Research
PloS one
Integrating smoking cessation into HIV care settings: A systematic review and meta-analysis of effectiveness and the evidence gap in cost-effectiveness.
1 Aug 2026
BMJ open ophthalmology
Screening for diabetic retinopathy with artificial intelligence in a primary care setting: a comparative cost analysis
1 Aug 2026
Preventing chronic disease
Reducing Rates of Cesarean Delivery in Rural US Communities: A Systematic Review of Interventions and Approaches to Care
31 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service